Sponsor:
Merck Sharp & Dohme LLC
Code:
NCT06459180
Conditions
Cervical Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab Tirumotecan
Pemetrexed
Tisotumab Vedotin
Topotecan
Vinorelbine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations